Flu virus changes every year, and that’s why yearly vaccination is the most effective way to help prevent flu and its complications.
The FLU SV MRNA-027 study is testing a new mRNA-based vaccine designed to protect against multiple flu virus strains, including those that may differ from the predicted strains.
This study will evaluate whether the investigational vaccine provides sufficient or better protection against seasonal flu compared to current vaccines, for participants who are more than 18 years of age.
Our vaccine aims to enhance the immune system’s ability to recognize and fight off multiple flu virus strains. This may reduce the severity of the illness and provide better defence, even when the vaccine isn’t an exact match for the flu strains circulating in a particular year.
If you are 18 years of age or older and would like to learn more about this study, please speak to your doctor.
Taking part in a clinical trial is voluntary. You are free to leave at any time and do not need to provide a reason.
